KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
8.96
-0.09 (-0.99%)
Nov 20, 2024, 4:00 PM EST - Market closed
KalVista Pharmaceuticals Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for KALV stock have an average target of 29, with a low estimate of 20 and a high estimate of 35. The average target predicts an increase of 223.66% from the current stock price of 8.96.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 7, 2024.
Analyst Ratings
The average analyst rating for KALV stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +123.21% | Oct 7, 2024 |
| Jones Trading | Jones Trading | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +290.62% | Sep 27, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +123.21% | Sep 6, 2024 |
| Needham | Needham | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +257.14% | Sep 6, 2024 |
Financial Forecast
Revenue This Year
27.65M
Revenue Next Year
77.24M
from 27.65M
Increased by 179.39%
EPS This Year
-3.02
from -3.44
EPS Next Year
-1.91
from -3.02
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 105.0M | 156.5M | 237.8M | ||
| Avg | 27.6M | 77.2M | 186.0M | ||
| Low | n/a | 40.2M | 138.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 466.3% | 207.9% | ||
| Avg | - | 179.4% | 140.8% | ||
| Low | - | 45.3% | 79.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -1.74 | -0.12 | 0.76 | ||
| Avg | -3.02 | -1.91 | -0.13 | ||
| Low | -3.76 | -2.54 | -0.79 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.